Navigation Links
DecisionView to Create Clinical Trial Enrollment Benchmarks
Date:6/16/2011

SAN FRANCISCO, June 16, 2011 /PRNewswire/ -- DecisionView Inc., a leading provider of software solutions to optimize clinical trial enrollment for life sciences companies, today announced that a number of pharmaceutical industry leaders including GlaxoSmithKline and Roche have agreed to participate in the creation of a set of industry patient enrollment benchmarks based on real-world clinical performance data. Each of the initial sponsors will contribute their historical enrollment data, which will be anonymized, aggregated, and made available to all participants via DecisionView's StudyOptimizer for use in benchmarking, planning and forecasting clinical trial enrollment.

"There is a huge demand for clinical performance data to inform and calibrate clinical trial planning," said Alex Lancksweert, Director of Performance & Supplier Governance at GlaxoSmithKline. "Unfortunately, current solutions are not integrated directly into our processes or tools, making it difficult to take advantage of them. We see a lot of value in leveraging the detailed enrollment performance data that already exists in StudyOptimizer to provide planning information at the point of need, in an accessible format."

"We fully support this effort to create the first industry-wide patient enrollment data set for benchmarking purposes," said Henk de Wilde, Global Head Information Management for Clinical Operations at Roche. "Organizations like Roche already have large, existing internal data sets available, but this internal data doesn't allow us to compare our performance to the rest of the market. And DecisionView is uniquely positioned to lead this initiative, since so many of the industry's leading life science firms already have their enrollment data hosted on StudyOptimizer."

Why An Enrollment Benchmarks Data Set?

There is significant demand for trusted clinical trial performance data across a number of different clinical operations processes
'/>"/>

SOURCE DecisionView Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DecisionView Launches StudyOptimizer(TM) 4
2. A Quiet Healing Environment Created by Nurse Call?
3. Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services
4. Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create Worlds Most Innovative and Comprehensive Orthopaedics Business
5. MedVantx and Blue Cross & Blue Shield of Rhode Island Partner to Provide Physicians with Integrated Medication Management Platform in Newly Created Patient-Centered Medical Homes
6. Six Health Plans Pay $1.5 Million in Incentives to Create Medical Homes for Nearly Half a Million Hudson Valley Residents
7. Software Development Firms New Intellectual Property Group, Blue Horseshoe IP Creates Solutions to Help Customers Optimize Supply Chain
8. Virtual Radiologic and Lakeland Radiologists Partner to Create Lakeland Radiology Alliance
9. New Ad Campaign: Secret Provision Raises Taxes on Prescription Drug Benefits, Creates Conflict of Interest
10. Novo Nordisk Creates First Mobile Application to Help Doctors Diagnose Bleeding Disorders
11. Exagens Corporate Expansion Creates Job Opportunities in New Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... BOSTON , Jan. 15, 2014 Tegra Medical is ... Mark King as its new Chief Executive Officer.  Mark ... in which he has overseen the company,s four facilities in ... and Costa Rica.  Mr. King joined Tegra Medical in 2012 ...
(Date:1/15/2014)... Inc. (Nasdaq: ECTE ) ("Echo"), a medical ... non-invasive, wireless continuous glucose monitoring system, today announced that ... CEO of Echo Therapeutics, will present at "TEN", Noble ... Mr. Doman will make a corporate presentation to ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... Boehringer Ingelheim Pharmaceuticals, Inc. today announced its pipeline ... 2 diabetes therapeutic area. The Company is investigating ... worldwide. New Phase II data results for linagliptin ... the Company,s lead diabetes compound, were presented today at ...
... , Two-year study presented at the American Diabetes ... to standard insulin therapy in pulmonary function tests ... AFRESA(R) (insulin human [rDNA origin]) Inhalation Powder is ... in pulmonary function tests comparable to usual antidiabetic ...
Cached Medicine Technology:Boehringer Ingelheim Unveils Diabetes Pipeline 2Boehringer Ingelheim Unveils Diabetes Pipeline 3Boehringer Ingelheim Unveils Diabetes Pipeline 4Boehringer Ingelheim Unveils Diabetes Pipeline 5AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA 2AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA 3
(Date:7/10/2014)... News) -- Most professional football players who have shoulder ... a new study finds. Shoulder instability is a ... return after surgery to fix the problem has been ... included 60 players who had shoulder stabilization surgery. Ninety ... to play, defined as playing in at least one ...
(Date:7/10/2014)... 10, 2014 (HealthDay News) -- Teens who are sensitive ... likely to develop emotional symptoms such as anxiety and ... as these that may exacerbate issues teens experience after ... and in making decisions about when to return to ... these athletes," study authors Lisa Koehl and Dong Han, ...
(Date:7/10/2014)... 2014 (HealthDay News) -- Men who have a vasectomy ... a new study suggests. But the risk is ... involved with the study said more research is needed ... For the study, Harvard researchers analyzed data from ... 24 years, starting in 1986. During that time, 6,023 ...
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July 10, 2014 ... use of calorie information on menus, if it,s available, to ... U.S. study. Women in particular review the menu labeling, ... with the U.S. Centers for Disease Control and Prevention. ... to help choose their meal, compared with just under half ...
(Date:7/10/2014)... Emergency Medical Service (EMS) responders felt better prepared to ... tactical training according to a new study in the ... the first study to specifically examine the EMS provider ... a shooter has not yet been neutralized or working ... such as the Columbine High School shooting, the Virginia ...
Breaking Medicine News(10 mins):Health News:Shoulder Surgery Gets NFL Players Back in the Game 2Health News:Some Teens May Face Emotional Problems After Concussion 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 3Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 3Health News:Active shooter training increases comfort level of emergency responders 2
... associated with Alzheimer,s and mad cow disease, turns out ... paper published in Nature Chemical Biology , Frederic ... Universiteit Brussel describe that certain mutations of p53, an ... a way that the proteins start to aggregate. This ...
... 29 (HealthDay News) -- Dangerous methicillin-resistant staphylococcus aureus, or MRSA, ... this seasonal increase is more common in children than adults, ... analysis of MRSA cases that occurred at Rhode Island Hospital, ... children,s infections were higher in the third and fourth quarters ...
... application provided by the UK Resuscitation Council performed significantly ... did not, according to a study in the April ... approximately 30,000 people in the UK have an unexpected ... resuscitation research, survival rates for adults suffering a cardiac ...
... that liver transplant recipients who quit smoking have a ... keep smoking. In fact, SRMs were identified in 13.5% ... higher risk of malignancy in this study. Full findings ... Transplantation , a journal of the American Association for ...
... News) -- Death rates among teens and young adults aged 15 ... 4 years in many countries, says a new study that ... of researchers that analyzed the causes and patterns of death among ... 2004 also found that death rates among young males aged 15 ...
... Severely obese men and women who have bariatric surgery may ... much of their pre-surgery risk for experiencing disabling migraines, researchers ... a small study of obese patients with a history of ... roughly 66 pounds by the half-year point following either laparoscopic ...
Cached Medicine News:Health News:Cancer is a p53 protein aggregation disease 2Health News:MRSA Infections May Vary by Season 2Health News:Free phone app helped doctors perform better in simulated cardiac emergency 2Health News:Smoking in combination with immunosuppression poses greater risk for transplant-related carcinoma 2Health News:Death Rates of Children, Young Adults Show Reversal 2Health News:Weight-Loss Surgery May Cut Migraine Pain in Obese Patients 2Health News:Weight-Loss Surgery May Cut Migraine Pain in Obese Patients 3
... CC 527 is an assayed quality control material ... electrolyte, and CO-Oximeter instrumentation. It is for specific ... and hemoglobin fractions (280, 288, and 270) and ... 527 may also be used on the IRMA ...
Equinox is a truly unique approach to cosmetic enhancement contact lenses and is worn as a conventional wear lens....
Cormet Hip Resurfacing is a conservative treatment for the young, active, high demand patient group which conserves femoral bone, provides anatomical bone loading, eliminates polyethylene and is desi...
For the qualitative detection of igG antibodies specific to Helicobacter pylori in human serum, plasma and whole blood specimens...
Medicine Products: